Related Experiment Video
Updated: Jun 28, 2025
03:47
Author Spotlight: Workflow for Integrating POCUS Data into EHR for Managing Heart Failure Patients
Published on: July 12, 2024
766
[Optimizing the management of heart failure: structuring the care pathway].
Valérie Blesse1, Romain Itier1, Ghislaine Galtier1
1Unité Icat, service de cardiologie, institut Cardiomet, CHU de Toulouse, hôpital Rangueil, 1 avenue du Pr Jean-Poulhès, TSA 50032, 31059 Toulouse cedex 9, France.
Soins; La Revue De Reference Infirmiere
|April 13, 2024
Summary
Chronic heart failure is increasing, requiring better multidisciplinary care. Optimized medical and nursing collaboration improves patient management and care pathways.
Area of Science:
- Cardiology
- Healthcare Management
Context:
- Rising incidence of chronic heart failure in Western countries.
- Need for optimized multidisciplinary healthcare organization.
Purpose:
- To describe the implementation of enhanced structures for heart failure patient management.
- To improve the patient care pathway within a specialized unit.
Summary:
- A multidisciplinary approach integrating medical and nursing expertise is crucial for managing escalating chronic heart failure cases.
- Toulouse University Hospital has established specific structures around its heart failure, assistance, and transplantation unit to enhance patient care.
Impact:
- Potential for improved patient outcomes and more efficient healthcare delivery for chronic heart failure.
- Establishes a model for specialized heart failure management adaptable to other institutions.
Related Concept Videos
01:17Pathophysiology of Heart Failure
1.6K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.6K
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
422
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
422
01:15Methods of Documentation VI: Case Management Model
570
The case management model is a multidisciplinary approach that involves healthcare professionals from diverse disciplines, such as physicians, nurses, therapists, social workers, and pharmacists, working collaboratively to address the various needs of patients. Each healthcare professional brings unique expertise and perspectives, contributing to a more comprehensive understanding of the patient's condition and tailoring treatment plans accordingly.
For example, a patient with a chronic...
For example, a patient with a chronic...
570
01:22Heart Failure Drugs: β-Blockers
337
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
337
01:22Heart Failure Drugs: Diuretics
370
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
370
01:26Heart Failure Drugs: Inotropic Agents
577
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
577